Cancer Phototherapy by CO Releasing Terpyridine-Based Re(I) Tricarbonyl Complexes via ROS Generation and NADH Oxidation

Rajesh Kushwaha,Aarti Upadhyay,Sukanta Saha,Ashish Kumar Yadav,Arpan Bera,Arnab Dutta,Samya Banerjee
DOI: https://doi.org/10.1039/d4dt01309c
IF: 4
2024-07-26
Dalton Transactions
Abstract:Here, we have synthesized and characterized three visible light responsive terpyridine based-Re(I)-tricarbonyl complexes; [Re(CO)3(ph-tpy)Cl] (Retp1), [Re(CO)3(an-tpy)Cl] (Retp2), and [Re(CO)3(py-tpy)Cl] (Retp3) where ph-tpy = 4'-phenyl-2,2':6',2''-terpyridine; an-tpy = 4'-anthracenyl-2,2':6',2''-terpyridine, py-tpy = 4'-pyrenyl-2,2':6',2''-terpyridine. The structure of Retp1 and Retp2 were confirmed from the SC-XRD data, indicating distorted octahedral structures. Unlike traditional PDT agents, these complexes generated reactive oxygen species (ROS) via type I and type II pathways and oxidized redox crucial NADH (reduced nicotinamide adenine dinucleotide) upon visible light exposure. Retp3 showed significant mitochondrial localization and demonstrated photoactivated anticancer activity (IC50 ⁓ 2 μM) by inducing ROS-mediated cell death in cancer cells selectively (photocytotoxicity Index, PI > 28) upon compromising mitochondrial function in A549 cells. Their diagnostic capabilities were ultimately assessed using clinically relevant 3D multicellular tumor spheroids (MCTs).
chemistry, inorganic & nuclear
What problem does this paper attempt to address?